Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
01/2004
01/01/2004US20040002506 Antiproliferative agents; antitumor agents
01/01/2004US20040002504 Psychological disorders; schizophrenia
01/01/2004US20040002503 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
01/01/2004US20040002501 Modulate signal transduction; antitumor, anticancer agents, vision defects, antidiabetic agents, antiinflammatory agents
01/01/2004US20040002500 Methods for treating attention deficit disorder
01/01/2004US20040002499 Antitumor agents; anticancer agents; mixture of curcumin and paclitaxel
01/01/2004US20040002498 Tricyclic compounds useful as HIV reverse transcriptase inhibitors
01/01/2004US20040002497 Autoimmune disease; antiinflammatory agents; antiischemic agents; antiarthritic agents
01/01/2004US20040002495 Lactam glycogen phosphorylase inhibitors and method of use
01/01/2004US20040002494 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
01/01/2004US20040002493 Benzoic acid derivatives and pharmaceutical agents comprising the same as active ingredient
01/01/2004US20040002491 Melatonergic receptors
01/01/2004US20040002490 Melatonergic receptors
01/01/2004US20040002488 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction
01/01/2004US20040002487 Bone disorders; osteoporosis; oral diseases; antiarthritic agents
01/01/2004US20040002485 Enzyme inhibitors; viricides
01/01/2004US20040002483 Use of ester and ether derivatives of 4-hydroxy-19-norandrosterone to increase the level of the anabolic/androgenic hormone 4-hydroxy-19-nortestosterone in humans
01/01/2004US20040002482 Androgen pharmaceutical composition and method for treating depression
01/01/2004US20040002481 Novel 4-dedimethylaminotetracycline derivatives
01/01/2004US20040002479 Proteasome inhibitors; bone disorders
01/01/2004US20040002477 Therapy for sexual disorders; chealte compound with cyclodextrin
01/01/2004US20040002476 Modified fluorinated nucleoside analogues
01/01/2004US20040002473 Pain modulation; incotinence therapy; central nervous system disorders
01/01/2004US20040002468 Methods of treating diabetes and other blood sugar disorders
01/01/2004US20040002466 Releasing interferon from complex of interferon and nucleic acids; antitumor agents, viricide, induction immunology response
01/01/2004US20040002463 Inhibitors and methods of use thereof
01/01/2004US20040002462 Combination therapy for effecting weight loss and treating obesity
01/01/2004US20040002461 Amelioration of the development of cataracts and other ophthalmic diseases
01/01/2004US20040002454 Administering polypeptides; cardiovascular disorders
01/01/2004US20040002451 Antiinflammatory agents; stability, reduced viscosity; immobilization
01/01/2004US20040002447 Induction of insulin expression
01/01/2004US20040002423 Remedies
01/01/2004US20040002134 Novel nucleic acid sequences encoding human KIAA0768 protein-like and human protein PRO228-like polypeptides
01/01/2004US20040002066 36 human secreted proteins
01/01/2004US20040001907 Slurrying flour and alcohol; sonication
01/01/2004US20040001899 Formulation for the prevention and treatment of multiple sclerosis and other demyelinating conditions
01/01/2004US20040001897 Skin vitalizing composition for external use anti-aging preparation
01/01/2004US20040001895 Combination treatment for depression and anxiety
01/01/2004US20040001892 Tunable, semi-interpenetrating polymer networks (sIPNS) for medicine and biotechnology
01/01/2004US20040001886 Hypotensive agents; cardiovascular disorders; mixture with microcrystalline cellulose, starch ethers, magnesium stearate and colloidal silica
01/01/2004US20040001885 Loratadine; wet granulation, blending
01/01/2004US20040001883 Meloxicam suppositories
01/01/2004US20040001881 Drug in pressure sensitive adhesive; vomiting, nausea therapy; side effect reduction
01/01/2004US20040001878 Suspension of starch hydrolyzates
01/01/2004US20040001875 Antidiabetic agents; controlling concentration of protein, carbohydrates, fats
01/01/2004US20040001873 Gelled delivery vehicle containing nutritional ingredients
01/01/2004US20040001872 Using polyoxyethylene glycol solutions; mixing with drug
01/01/2004US20040001871 Lapachone delivery systems, compositions and uses related thereto
01/01/2004US20040001868 Aerosol mixture of lipid crystals with propellant
01/01/2004US20040001862 Herbal plant extracts
01/01/2004US20040001844 Lewis Y epitope-containing mucin fusion polypeptide vaccines, compositions and methods of use thereof
01/01/2004US20040001841 Use of biomolecular targets in the treatment and visualization of brain tumors
01/01/2004US20040001838 Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same
01/01/2004US20040001835 Prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents
01/01/2004US20040001833 Method of treating cancer using kinase inhibitors
01/01/2004US20040001831 Methods and compositions for the diagnosis and treatment of demyelinating inflammatory disorders
01/01/2004US20040001818 Prevention endothelial cell migration; antiproliferative agent; diaphorase inhibitor
01/01/2004US20040001817 Mixture of vitamions, minerals, digestive enzyme, hormone and amino acids
01/01/2004US20040001811 Compositions and methods for inhibiting expression of anti-apoptotic genes
01/01/2004US20040001800 Hemo-and biocompatible polymeric adsorbing material, method of producing the material, and method of and device for purification of physiological fluids of organism with the use of the material
01/01/2004US20040001797 Antimicrobial compositions, products and methods employing same
01/01/2004US20040001792 Decoloring hair and skin using ascorbic acid
01/01/2004US20040001791 Composition, method of use, and devices for the treatment of onychomycosis
12/2003
12/31/2003WO2004001424A1 Materials and methods for inductions of immune tolerance
12/31/2003WO2004001072A2 Method for diagnosis of colorectal tumors
12/31/2003WO2004001059A2 Heterocyclic inhibitors of kinases
12/31/2003WO2004001053A1 β-GLUCAN-CONTAINING FAT COMPOSITIONS AND NOVEL MICROORGANISM PRODUCING β-GLUCAN
12/31/2003WO2004001035A1 Method for generating monoclonal antibodies
12/31/2003WO2004001021A1 Pasteurisation process for microbial cells and microbial oil
12/31/2003WO2004001002A2 Novel anticholesterol compositions and method for using same
12/31/2003WO2004000979A1 Process for recovery of plant sterols from by-product of vegetable oil refining
12/31/2003WO2004000918A1 Hydrous gel and production process and use of the hydrous gel
12/31/2003WO2004000887A1 Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same
12/31/2003WO2004000869A1 Glucocorticoid receptor ligands for the treatment of metabolic disorders
12/31/2003WO2004000868A1 Oligonucleotide directed misfolding of rna
12/31/2003WO2004000866A1 11-c-substituted derivatives of clarithromycin
12/31/2003WO2004000865A1 Pharmaceutical compositions of azithromycin
12/31/2003WO2004000858A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
12/31/2003WO2004000856A1 Combination of a reflux inhibitor and an imidazopyridine for the treatment of gerd
12/31/2003WO2004000854A1 Sulfur-containing phospholipid derivatives
12/31/2003WO2004000849A2 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity
12/31/2003WO2004000846A1 Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors
12/31/2003WO2004000845A1 Arylalkyl indoles having sertonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
12/31/2003WO2004000843A1 NOVEL PURINE- OR PYRROLOL[2,3-d]PYRIMIDINE-2-CARBONITILES FOR TREATING DISEASES ASSOCIATED WITH CYSTEINE PROTEASE ACTIVITY
12/31/2003WO2004000842A1 Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors
12/31/2003WO2004000841A1 Hetero-bicyclic compounds
12/31/2003WO2004000840A2 Quinuclidine derivatives and pharmaceutical compositions containing the same
12/31/2003WO2004000839A1 Thiazole derivatives as phosphodiesterase iv inhibitors
12/31/2003WO2004000837A1 Novel benzoxazolinone derivative
12/31/2003WO2004000836A1 Hydroxy pyranone derivative and preparation method thereof
12/31/2003WO2004000834A1 Novel 3-(4-oxo-4h-chromen-2-yl)-(1h)-quinoline-4-one derivatives, method for preparing same and pharmaceutical compositions containing same
12/31/2003WO2004000833A1 Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase
12/31/2003WO2004000832A1 1-[(indol-3-yl)carbonyl] piperazine derivatives
12/31/2003WO2004000831A1 Indole derivatives useful as histamine h3 antagonists
12/31/2003WO2004000830A1 Novel compounds, their use and preparation
12/31/2003WO2004000829A1 Novel process
12/31/2003WO2004000828A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders
12/31/2003WO2004000825A1 Novel compounds
12/31/2003WO2004000823A1 Amorphous form of(-)-}2-}4-}(4-chlorophenyl)-phenyl methyl}-1-piperazinyl] ethoxy] acetic acid dihydrochloride (levocetririzine dihydrochloride)
12/31/2003WO2004000822A1 2-thioxothiazole derivative, method for preparing the same, and pharmaceutical composition containing the same